Alder Biopharma (ALDR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Operating Expenses | 55,758 | 114,087 | 77,774 | 58,478 | 64,729 |
| Operating Income | -55,758 | -114,087 | -77,774 | -58,478 | -64,729 |
| Interest Expense | 4,975 | 4,838 | 4,863 | 4,783 | 4,688 |
| Other Income | 2,322 | 991 | 2,548 | 2,341 | 1,028 |
| Pre-tax Income | -58,411 | -117,934 | -80,089 | -60,920 | -68,389 |
| Net Income Continuous | -58,411 | -117,934 | -80,089 | -60,920 | -68,389 |
| Net Income | $-58,411 | $-117,934 | $-80,089 | $-60,920 | $-68,389 |
| EPS Basic Total Ops | -0.72 | -1.63 | -1.19 | -0.91 | -1.04 |
| EPS Basic Continuous Ops | -0.70 | -1.61 | -1.17 | -0.89 | -1.01 |
| EPS Diluted Total Ops | -0.72 | -1.63 | -1.19 | -0.91 | -1.04 |
| EPS Diluted Continuous Ops | -0.70 | -1.61 | -1.17 | -0.89 | -1.01 |
| EPS Diluted Before Non-Recurring Items | -0.72 | -1.63 | -1.19 | -0.91 | -1.04 |
| EBITDA(a) | $-55,221 | $-113,554 | $-77,352 | $-57,941 | $-63,922 |